Canada Pension Plan Investment Board’s Travere Therapeutics TVTX Stock Holding History

Canada Pension Plan Investment Board’s Portfolio TVTX Stock Details TVTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$241K	Sell	8,100 -1,000	-11%	-$29.9K	﹤0.01%	1505
2025 Q4	$348K	Buy	+9,100	New	+$296K	﹤0.01%	1452
2024 Q1	–	Sell	-224,000	Closed	-$2.01M	–	1260
2023 Q4	$2.01M	Hold	224,000	–	–	﹤0.01%	840
2023 Q3	$2M	Buy	+224,000	New	+$3.16M	﹤0.01%	766
2022 Q2	–	Sell	-731,000	Closed	-$18.8M	–	1376
2022 Q1	$18.8M	Buy	731,000 +220,000	+43%	+$5.84M	0.03%	398
2021 Q4	$15.9M	Buy	511,000 +53,000	+12%	+$1.49M	0.02%	482
2021 Q3	$11.1M	Buy	458,000 +100,000	+28%	+$1.84M	0.01%	555
2021 Q2	$5.22M	Buy	+358,000	New	+$7.06M	0.01%	637

Other funds holding TVTX

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Canada Pension Plan Investment Board's TVTX Position: Q1 2026 in Review

Canada Pension Plan Investment Board reduced its Travere Therapeutics (TVTX) stake by 11% in Q1 2026, selling an estimated $29.9K and leaving 8,100 shares worth $241K. The position accounts for ﹤0.01% of the portfolio, ranked #1505.

Canada Pension Plan Investment Board first reported a position in TVTX in Q2 2021 and has held it in 8 quarters since. The position peaked at $18.8M in Q1 2022. 260 funds tracked by Wall St. Rank hold TVTX as of Q1 2026.

Canada Pension Plan Investment Board held 8,100 shares of Travere Therapeutics worth $241K as of Q1 2026.
Canada Pension Plan Investment Board sold 1,000 Travere Therapeutics shares in Q1 2026, an estimated $29.9K.
Travere Therapeutics made up ﹤0.01% of Canada Pension Plan Investment Board's portfolio in Q1 2026, its #1505 holding.
Canada Pension Plan Investment Board first reported a position in Travere Therapeutics in Q2 2021 and has held it in 8 quarters since.
Canada Pension Plan Investment Board's Travere Therapeutics position peaked at $18.8M in Q1 2022.
260 funds tracked by Wall St. Rank held Travere Therapeutics as of Q1 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q1 2026, filed 15 May 2026.